H.R. 10359
Makes rare pediatric disease drug vouchers permanent
Removes the end date on a program that gives drug makers faster review of a future medicine when they develop a treatment for a rare disease in children.
- Ends the current expiration of the priority review voucher program
- A voucher means faster review of one future drug application
- Covers products for rare diseases that affect children
In committee